Wheeler Bio

Wheeler Bio Contract Manufacturing & Development (CDMO) Profile

Niche Biopharmaceutical CDMO. Wheeler Bio brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck with a unique partnering model, built on shared success and lasting collaborations. The typical momentum drop between discovery and development poses significant challenges for emerging biopharma companies adding technical, financial, and regulatory risks. We believe these lifecycle challenges can be reduced with more democratization of manufacturing platforms.

Wheeler is proud to currently offer best-in-class mammalian cell line and process development, GLP Tox material supply, and efficient CGMP clinical supply.

CDMO Services:
Biologics Liquids Analytical Development; Cell Line Development; Formulation Development; ICH Stability Testing; Process Development; Protein Synthesis Antibodies; Fusion Proteins; Recombinants + other Proteins; Protein Vaccines

Year Founded: 2020

Head Office: Oklahoma City, United States

Number of Facilities: 1-2

Facility locations: North America

Website: Visit the Wheeler Bio website

Linkedin: Connect on Linkedin

Current Capacity: 1x 500 L

2x50L